10-KThe Record
STANDARD BIOTOOLS INC. files 10-K
Filed Mar 16, 2026 · 3mo ago · Accession 0001193125-26-108326
Plain English
Standard BioTools Inc. reported a net loss of $74.9 million for the year ended December 31, 2025, a decrease from the $138.9 million net loss in the prior year, driven by a decline in revenue and restructuring charges. The company completed the divestiture of its SomaScan Business to Illumina on January 30, 2026.
Filing details
- Company
- STANDARD BIOTOOLS INC.
- Ticker
- LAB
- CIK
- 1162194
- Form type
- 10-K
- Filing date
- Mar 16, 2026
- Report date
- Dec 31, 2025
- Document
- lab-20251231.htm
- Size
- 34.5 MB